Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 36.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 68.00
  • 52 Week Low: 31.50
  • Currency: UK Pounds
  • Shares Issued: 43.87m
  • Volume: 2,072
  • Market Cap: £16.01m
  • RiskGrade: 219

Destiny Pharma Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

Key Personnel

CEO: Neil Clark
CFO and Company Secretary: Shaun Claydon
Chairman: Nick Rodgers
Chief Scientific Officer: William Love
Independent Non-Executive Director: Debra Barker
Non-Executive Dir: Peter Morgan, Huaizheng Peng

Contact Details

Address: Unit 36,Sussex Innovation Centre,Science Park Square,Falmer,Brighton, BN1 9SB
Phone: +44 (0)1273 704 440
Website: http://www.destinypharma.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BDHSP575

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 36.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 68.00
52 Week Low 31.50
Volume 2,072
Shares Issued 43.87m
Market Cap £16.01m
RiskGrade 219

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.54% below the market average20.54% below the market average20.54% below the market average20.54% below the market average20.54% below the market average
1.82% above the sector average1.82% above the sector average1.82% above the sector average1.82% above the sector average1.82% above the sector average
Price Trend
53.29% below the market average53.29% below the market average53.29% below the market average53.29% below the market average53.29% below the market average
82.46% below the sector average82.46% below the sector average82.46% below the sector average82.46% below the sector average82.46% below the sector average
Income Not Available
Growth Not Available

Destiny Pharma Dividends

No dividends found

Trades for 13-Jul-2020

Time Volume / Share Price
08:10 103 @ 36.60p
08:00 1,307 @ 36.60p
08:00 662 @ 36.60p

Destiny Pharma Key Personnel

CEO Neil Clark
Chair Nick Rodgers

Top of Page